Mannose
metaboliteMannose reflects altered carbohydrate metabolism and systemic stress in acute myocardial infarction.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencelow
RationaleSimple sugar; systemic metabolic marker associated with MI mortality risk but not plaque-specific.
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I70
C — confounder / Type-II93
A — assay feasibility42
E — evidence strength35
T1DI (composite)6
Specificity differential (R−C)-22.8
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(1)
Clinical trials(2)
- Influence of Periodontal Disease Treatment on Serum Levels of Sirtuin 1 and Mannose-binding Lectin in Individuals With Coronary Artery DiseaseNCT03753451 · NA · COMPLETED · treatment of periodontal disease
- Associations Between Serum Lipids and Mannose Levels in Coronary Artery Disease Among Nondiabetic PatientsNCT04888260 · COMPLETED · Laboratory parameter levels in blood samples